Compound Monograph

Protopine

Alkaloids Isoquinoline Alkaloids Natural (plant-derived)

Protopine is a protopine-type isoquinoline alkaloid of California poppy, greater celandine, corydalis and other poppy/fumitory plants — a ring-expanded bridge between the protoberberines and the benzophenanthridines. Its interest is polypharmacology: a reversible CYP2D6 and acetylcholinesterase inhibitor with antiplatelet, cation-channel, analgesic and monoamine-reuptake actions, almost all of it preclinical.

Sources · 9

Where Does It Come From?

Protopine is a naturally occurring isoquinoline alkaloid (protopine-type group), found in California poppy, Greater celandine, Corydalis and 6 other sources. It is flagged as moderately toxic.

Also found in
Bleeding heart Monograph coming soon
Bloodroot Monograph coming soon
Fumitory Monograph coming soon
Heavenly bamboo Monograph coming soon
Opium poppy Monograph coming soon
Plume poppy Monograph coming soon

Concentration

Content by Source

Reported concentrations across the plants that contain protopine — the bar marks the typical level, the line shows the reported range.

Typical level Reported range mg/g product
California poppy (Eschscholzia californica) commercial preparation 0.008–0.2 [13]

Literature figures for varying plant parts and preparations. Read them as a comparative guide, not exact assays.

Protopine at a Glance

Protopine is a minor isoquinoline alkaloid that turns up across the poppy and fumitory families — California poppy, greater celandine, corydalis, fumitory, bloodroot and others — many of them herbs with a long traditional reputation as calming, sleep-supporting or pain-relieving remedies.

It is the namesake of the protopine-type alkaloids, and its interest is polypharmacology rather than one headline effect. Across preclinical work protopine reads as a broad, moderate, reversible modulator: it inhibits acetylcholinesterase and the drug-metabolising enzyme CYP2D6, damps platelet aggregation, blocks cardiac and neuronal cation channels, produces analgesia through voltage-gated sodium channels and opioid receptors, and inhibits the serotonin and noradrenaline transporters 1,2,3,4,5,6,8Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study →Reference 3Xu LF et al. · 2006AnimalProtopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice modelsView study →Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →Reference 5Kim SR et al. · 1999Protopine from Corydalis ternata has anticholinesterase and antiamnesic activitiesView study →Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →.

The honest posture is the usual compound-page discipline: almost all of this is in-vitro or rodent work on the isolated molecule, and there are no human efficacy trials. Protopine is also frequently grouped with the “MAO-inhibiting” poppy alkaloids — but its documented monoaminergic action is transporter (reuptake) inhibition, not monoamine-oxidase inhibition (see the scope note below).

Protopine’s Place: A Ring-Expanded Bridge Between Protoberberines & Benzophenanthridines

Protopine’s structure explains why it behaves the way it does. Where the tetrahydroprotoberberines (THPBs such as canadine and tetrahydropalmatine) have a compact four-ring, nitrogen-bridged core, protopine’s central ring has been oxidatively opened and re-formed into a larger ten-membered ring carrying a ketone — the defining trait of the protopine-type class.

In benzylisoquinoline biosynthesis this is a way-station, not an endpoint. The pathway runs (S)-scoulerine → cheilanthifoline → stylopine → cis-N-methylstylopine → protopine → dihydrosanguinarine → sanguinarine. Protopine therefore sits biochemically between the protoberberines it is made from (the berberine / palmatine / coptisine family) and the benzophenanthridines it is made into (sanguinarine, chelerythrine). That is exactly why one plant — California poppy, greater celandine, bloodroot or corydalis — routinely carries all three classes at once, protopine alongside its close protopine-type relative allocryptopine.

The in-between-ness is pharmacological as well as structural. Protopine keeps some of the smooth-muscle and enzyme-modulating character of the protoberberines, but lacks the flat, quaternary, cytotoxic cation chemistry of the benzophenanthridines — so it is far less cytotoxic than sanguinarine or chelerythrine, and its profile is one of broad, moderate, reversible modulation rather than a single potent hit 1Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →.

Protopine’s Multi-Target Pharmacology

The point of protopine is that it does several small things at once, and no one of them dominates. Five reasonably well-characterised actions recur across the literature:

  • Reversible enzyme inhibition. Protopine is a reversible, competitive acetylcholinesterase inhibitor 5Reference 5Kim SR et al. · 1999Protopine from Corydalis ternata has anticholinesterase and antiamnesic activitiesView study → and a reversible inhibitor of CYP2D6 2Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study → — a recurring “reversible modulator” theme rather than irreversible, covalent chemistry.
  • Cation-channel modulation. In isolated cardiac myocytes it is a promiscuous blocker of sodium, L-type calcium and potassium currents 8Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →; in sensory neurons it inhibits the pain-signalling Nav1.7 sodium channel 4Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →; and in platelets and vascular tissue it lowers intracellular calcium 6,7Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 7Shen ZQ et al. · 1999Effect of protopine on cytosolic Ca2+ in rabbit plateletsView study →.
  • Antiplatelet activity. It suppresses thromboxane A₂ formation and phosphoinositide breakdown, reducing platelet calcium and aggregation across multiple agonists 6,7Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 7Shen ZQ et al. · 1999Effect of protopine on cytosolic Ca2+ in rabbit plateletsView study →.
  • Analgesia. Central protopine is antinociceptive through opioid-receptor and sodium-channel routes 1,4Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →.
  • Monoaminergic action. It inhibits the serotonin and noradrenaline transporters (SERT/NET), giving an antidepressant-like effect in mice 3Reference 3Xu LF et al. · 2006AnimalProtopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice modelsView study →.

That same breadth is a double-edged property: the cardiac Nav1.5 / cation-channel activity that could look antiarrhythmic is also the molecule’s main safety flag (see Toxicity).

On the “MAO” claim. Protopine is often lumped with the monoamine-oxidase-inhibiting poppy alkaloids, and the framing does not survive checking. The documented mechanism behind its monoaminergic/antidepressant-like effect is reuptake-transporter (SERT/NET) inhibition 3Reference 3Xu LF et al. · 2006AnimalProtopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice modelsView study →, and the comprehensive 2022 pharmacology review reports no MAO-A/MAO-B inhibition data for protopine 1Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →. No verified reversible-MAO claim is made here; the reversible-enzyme story that is supported is CYP2D6 and acetylcholinesterase 2,5Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study →Reference 5Kim SR et al. · 1999Protopine from Corydalis ternata has anticholinesterase and antiamnesic activitiesView study →.

What It's Used For

The evidence is preclinical throughout, and splits by system rather than by a single indication. Read each row for what kind of study it rests on — most are in-vitro or rodent, on the isolated alkaloid.

A genuine multi-target profile (preclinical):reversible acetylcholinesterase and CYP2D6 inhibition, antiplatelet action via thromboxane/calcium, cation-channel block (Nav1.7 analgesia; cardiac Na⁺/Ca²⁺/K⁺), and SERT/NET reuptake inhibition — each replicated in isolated-molecule studies 2,3,4,5,6,8Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study →Reference 3Xu LF et al. · 2006AnimalProtopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice modelsView study →Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →Reference 5Kim SR et al. · 1999Protopine from Corydalis ternata has anticholinesterase and antiamnesic activitiesView study →Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →.
Analgesia is the most translationally interesting signal:central protopine is antinociceptive through opioid receptors and by inhibiting the pain-channel Nav1.7 — but the same work shows it also hits the cardiac channel Nav1.5, raising a heart-safety flag 1,4Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →.
The honest headline:there are no human efficacy trials; the monoaminergic action is transporter (reuptake) inhibition, not MAO inhibition; and protopine is a minor constituent of the plants it occurs in, so whole-herb effects should not be pinned on it alone 1,3Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →Reference 3Xu LF et al. · 2006AnimalProtopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice modelsView study →.
Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row here is preclinical isolate work, so scores stay modest by design; each application links to its write-up.

Mechanisms

Target / pathwayEffectRelevant to
Acetylcholinesterasereversible, competitive inhibition (IC₅₀ ≈ 50 µM)
anticholinesterase / cognition
CYP2D6reversible inhibition (interaction-relevant)
pharmacokinetics / drug interactions
Voltage-gated Na⁺ channel Nav1.7inhibition → peripheral analgesia
analgesia
Voltage-gated Na⁺ channel Nav1.5 (cardiac)inhibition → conduction slowing (cardiac liability)
analgesia / toxicity
L-type Ca²⁺ & K⁺ currents (myocytes)promiscuous block; shortened action potential
cardiac / antiarrhythmic
Platelet thromboxane synthase / phospholipase↓ TXA₂, ↓ phosphoinositide breakdown, ↓ [Ca²⁺]ᵢ
antiplatelet
Opioid receptors (central)naloxone-reversible antinociception
analgesia
SERT / NETreuptake inhibition → antidepressant-like
monoaminergic
NF-κB (IκB) / MAPK (p38, ERK, JNK)↓ iNOS, COX-2, TNF-α, IL-1β, IL-6
anti-inflammatory
GABAA receptorallosteric modulation (as a poppy-alkaloid constituent)
anxiolytic / sedative

The unifying read is a broad, reversible, mostly ion-channel-and-enzyme modulator. Its non-selectivity is both the appeal (many small effects) and the hazard (the analgesic sodium-channel block does not spare the heart).

Pharmacokinetics

Human pharmacokinetics for protopine are poorly characterised — the comprehensive review flags this as a major gap 1Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →. What is known is mostly rodent and in-vitro. Protopine is highly permeable across intestinal (Caco-2) monolayers, consistent with good absorptive potential 13Reference 13Chauveau A et al. · 2023Alkaloids in commercial preparations of California poppy — quantification, intestinal permeability and microbiota interactionsView study →, but no reliable oral-bioavailability figure or plasma half-life is established here. Its metabolism proceeds by ring cleavage, demethylation and glucuronidation, with around twelve metabolites identified in rats and reported sex differences in urinary/faecal excretion 1Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →. On the interaction side, protopine is a reversible CYP2D6 inhibitor 2Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study → and has been studied for CYP1A induction in human hepatocytes/HepG2 cells, where the effect was judged unlikely to be a practical safety problem 1Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →. Robust human ADME — Cmax, half-life, isolate bioavailability — is not available.

Clinical Trials

None for isolated protopine. No registered or published human efficacy trials of protopine as a stand-alone agent were identified; the entire evidence base is preclinical (isolated molecule) plus whole-herb traditional use of the source plants.

CompletedPlannedTerminatedPreclinical
———Extensive(isolate: analgesic, antiplatelet, anti-inflammatory, enzyme/channel)

Last checked: July 2026.

Isolate vs. Plant Studies

Protopine’s evidence is almost entirely the isolated molecule — purified from corydalis, celandine or Dactylicapnos and tested in cells, isolated tissue or rodents 3,4,5,6,8Reference 3Xu LF et al. · 2006AnimalProtopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice modelsView study →Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →Reference 5Kim SR et al. · 1999Protopine from Corydalis ternata has anticholinesterase and antiamnesic activitiesView study →Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →. That is methodologically clean, but it leaves a wide gap to human use, because in the plants people actually take, protopine is a minor alkaloid sitting in a complex mixture. The calming, analgesic and antispasmodic reputations of California poppy, greater celandine and corydalis are whole-extract, multi-alkaloid properties — greater celandine’s activities, for instance, are reviewed as products of its full isoquinoline-alkaloid complement, not protopine alone 11,12Reference 11Colombo ML · 1996Pharmacological activities of Chelidonium majus L. (Papaveraceae)View study →Reference 12Gilca M et al. · 2010ReviewChelidonium majus — an integrative review: traditional knowledge versus modern findingsView study →. The transferability caveat therefore cuts hard: do not read protopine’s isolated-channel or enzyme data onto a cup of poppy tea, and do not assume the herb’s traditional effect is “the protopine in it.”

Prevalence in Nature

Protopine is widespread but minor across several alkaloid-rich families — chiefly the Papaveraceae (California poppy, greater celandine, bloodroot, Macleaya), Fumariaceae/Fumaria (fumitory, Dactylicapnos, corydalis), and scattered Berberidaceae and Ranunculaceae 1Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →. It co-occurs with its protopine-type sibling allocryptopine, with the protoberberines (berberine, coptisine, palmatine) it is biosynthesised from, and with the benzophenanthridines (sanguinarine, chelerythrine) it is a precursor to.

Concrete abundance figures are scarce, which is the honest state of the data. The best-quantified source is commercial California-poppy preparations, where protopine was measured at 0.008–0.200 mg per gram of product by UHPLC-MS/MS — well below the plant’s dominant alkaloids californidine and escholtzine 13Reference 13Chauveau A et al. · 2023Alkaloids in commercial preparations of California poppy — quantification, intestinal permeability and microbiota interactionsView study →. In these aerial-part products protopine is one of the minor, ethanol-extractable alkaloids; it tends to concentrate more in roots than aerial parts, and content varies with species, plant part and preparation 1,13Reference 1Huang W et al. · 2021ReviewIdentification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A ReviewView study →Reference 13Chauveau A et al. · 2023Alkaloids in commercial preparations of California poppy — quantification, intestinal permeability and microbiota interactionsView study →.

Discovery & Synthesis

Protopine is one of the classical Papaveraceae alkaloids, long known under the older name fumarine (from its occurrence in Fumaria) and also as macleyine; its precise first-isolation date and discoverer are not established here. In the plant it is not synthesised from scratch as an endpoint but formed on the benzylisoquinoline pathway — the tetrahydroprotoberberine cis-N-methylstylopine is oxidatively rearranged (ring expansion to the ten-membered keto-bridged system) to give protopine, which is then carried on toward the benzophenanthridines. For research, protopine is obtained by extraction from alkaloid-rich plants (corydalis, greater celandine, Macleaya cordata, which is a commercial source of protopine-type “total alkaloids”); there is no large-scale total-synthetic manufacture, and no stand-alone drug product, driving demand.

Patents: not yet researched.

Toxicity & Safety

Protopine carries a moderate flag. The reason is not general cytotoxicity — as a protopine-type alkaloid it is markedly less cytotoxic than the benzophenanthridines it is related to, and a placental-cell safety panel found it “inconspicuous” for genotoxicity at low-micromolar concentrations (with viability falling only at the top 30 µM dose) 14Reference 14Spiess D et al. · 2022In vitroAdvanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in PregnancyView study →. The flag is driven instead by its non-selective cardiac ion-channel activity: the same block of Nav1.5 and L-type calcium/potassium currents that looks antiarrhythmic in isolated myocytes also means protopine can perturb cardiac electrophysiology, and the Corydalis yanhusuo analgesia study reported raised CK-MB (a cardiac-injury marker) with protopine, singling it out as the more cardiotoxic of the herb’s analgesic alkaloids 4,8Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →.

For the isolated alkaloid, acute toxicity is only well-documented for mixed protopine-type “total alkaloids” (from Macleaya cordata), which gave an oral LD₅₀ of ~482 mg/kg in mice, with negative mutagenicity and no teratogenicity in the tested range — but that is a fraction, not pure protopine, so it bounds rather than defines the isolate’s safety 16Reference 16Dong Z et al. · 2022AnimalAcute, chronic, and genotoxic studies on the protopine total alkaloids of the Macleaya cordata (Willd.) RView study →.

Drug-interaction note (enzyme-named): protopine is a reversible CYP2D6 inhibitor 2Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study →, so a theoretical interaction exists with CYP2D6 substrates; and its antiplatelet action 6,7Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 7Shen ZQ et al. · 1999Effect of protopine on cytosolic Ca2+ in rabbit plateletsView study → is an additive-bleeding caution alongside anticoagulant/antiplatelet drugs. Neither has been characterised clinically. Pregnancy/lactation was not adjudicated here — an in-vitro pregnancy-safety screen of protopine was reassuring at clinically relevant concentrations 14Reference 14Spiess D et al. · 2022In vitroAdvanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in PregnancyView study →, but that decision belongs to the whole-herb or product page where intake is decided, not to this molecule page.

Safety at a Glance
Moderate toxicity
  • Low intrinsic cytotoxicity / genotoxicity. Far less cytotoxic than its benzophenanthridine relatives; genotoxicity-inconspicuous at low-micromolar levels in a placental-cell panel 14Reference 14Spiess D et al. · 2022In vitroAdvanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in PregnancyView study →.
  • Cardiac ion-channel liability. Non-selective block of cardiac Na⁺ (Nav1.5), Ca²⁺ and K⁺ currents; protopine raised the cardiac marker CK-MB in the corydalis analgesia study 4,8Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →.
  • Reversible CYP2D6 inhibition. A theoretical interaction with CYP2D6-metabolised drugs; not clinically quantified 2Reference 2Manda VK et al. · 2016Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its AlkaloidsView study →.
  • Additive antiplatelet effect. In-vitro platelet inhibition means a plausible bleeding-risk caution with anticoagulant/antiplatelet medication 6,7Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 7Shen ZQ et al. · 1999Effect of protopine on cytosolic Ca2+ in rabbit plateletsView study →.
  • Human safety largely uncharacterised. No human toxicology; pure-isolate acute data are inferred from mixed-alkaloid fractions 16Reference 16Dong Z et al. · 2022AnimalAcute, chronic, and genotoxic studies on the protopine total alkaloids of the Macleaya cordata (Willd.) RView study →.

Dosage

There is no established or recommended human dose for isolated protopine. It has never been used as a stand-alone medicine, and human exposure is only ever indirect — as a minor alkaloid within a California-poppy, corydalis, greater-celandine or fumitory preparation, where the “dose of protopine” is whatever trace amount the plant and preparation happen to contain (on the order of hundredths to tenths of a milligram per gram of product) 13Reference 13Chauveau A et al. · 2023Alkaloids in commercial preparations of California poppy — quantification, intestinal permeability and microbiota interactionsView study →. Every figure in the sections above is a research value — micromolar concentrations in cells and isolated tissue (e.g. AChE IC₅₀ ≈ 50 µM 5Reference 5Kim SR et al. · 1999Protopine from Corydalis ternata has anticholinesterase and antiamnesic activitiesView study →; platelet and myocyte effects at tens of µM 6,8Reference 6Ko FN et al. · 1989Antiplatelet effects of protopine isolated from Corydalis tubersView study →Reference 8Song LS et al. · 2000Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currentsView study →) or rodent doses in mg/kg (e.g. analgesia at 10–40 mg/kg 4Reference 4Xu Y et al. · 2021Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channelsView study →). These are doses studied in research and are not a personal recommendation.

References

  1. Huang W, Kong L, Cao Y, Yan L. (2021). Identification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A Review. Molecules. https://pubmed.ncbi.nlm.nih.gov/35011447/
  2. Manda VK, Ibrahim MA, Dale OR, Kumarihamy M, Cutler SJ, Khan IA, et al. (2016). Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its Alkaloids. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/27054913/
  3. Xu LF, Chu WJ, Qing XY, Li S, Wang XS, Qing GW, et al. (2006). Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacology. https://pubmed.ncbi.nlm.nih.gov/16530230/
  4. Xu Y, et al. (2021). Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo) is caused by inhibition of voltage gated sodium channels. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/34329712/
  5. Kim SR, Hwang SY, Jang YP, Park MJ, Markelonis GJ, Oh TH, Kim YC. (1999). Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/10232064/
  6. Ko FN, Wu TS, Lu ST, Wu YC, Huang TF, Teng CM. (1989). Antiplatelet effects of protopine isolated from Corydalis tubers. Thrombosis Research. https://pubmed.ncbi.nlm.nih.gov/2559491/
  7. Shen ZQ, Chen ZH, Duan L. (1999). Effect of protopine on cytosolic Ca2+ in rabbit platelets. Zhongguo Yao Li Xue Bao (Acta Pharmacologica Sinica). https://pubmed.ncbi.nlm.nih.gov/10452120/
  8. Song LS, Ren GJ, Chen ZL, Chen ZH, Zhou ZN, Cheng H. (2000). Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currents. British Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/10696087/
  9. Alam MB, Ju MK, Kwon YG, Lee SH. (2019). Protopine attenuates inflammation stimulated by carrageenan and LPS via the MAPK/NF-κB pathway. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/31220533/
  10. Fedurco M, Gregorová J, Šebrlová K, Kantorová J, Peš O, Baur R, et al. (2015). Modulatory Effects of Eschscholzia californica Alkaloids on Recombinant GABAA Receptors. Biochemistry Research International. https://pubmed.ncbi.nlm.nih.gov/26509084/
  11. Colombo ML, Bosisio E. (1996). Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological Research. https://pubmed.ncbi.nlm.nih.gov/8870028/
  12. Gilca M, Gaman L, Panait E, Stoian I, Atanasiu V. (2010). Chelidonium majus — an integrative review: traditional knowledge versus modern findings. Forschende Komplementärmedizin. https://pubmed.ncbi.nlm.nih.gov/20980763/
  13. Chauveau A, Geirnaert A, Babst A, Treyer A, Lacroix C, Hamburger M, Potterat O. (2023). Alkaloids in commercial preparations of California poppy — quantification, intestinal permeability and microbiota interactions. Biomedicine & Pharmacotherapy. https://pubmed.ncbi.nlm.nih.gov/37673017/
  14. Spiess D, Winker M, Dolder Behna A, Gründemann C, Simões-Wüst AP. (2022). Advanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in Pregnancy. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/35814220/
  15. Kalyniukova A, et al. (2025). Comprehensive Metabolomic Profiling and Biological Activity Analysis of Eschscholzia californica Extracts Using LC-ESI-QTOF-MS. Food Science & Nutrition. https://pubmed.ncbi.nlm.nih.gov/40909255/
  16. Dong Z, Tang SS, Ma XL, Tan B, Tang ZS, Li CH, et al. (2022). Acute, chronic, and genotoxic studies on the protopine total alkaloids of the Macleaya cordata (Willd.) R. Br. in rodents. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/36249819/